
样式: 排序: IF: - GO 导出 标记为已读
-
Mast cells activated in vitro can modulate macrophage polarization and antibacterial responses. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2025-05-26
Dorothea B Holter,Sophie Zahalka,Jessica Brösamlen,Mariem Radhouani,Martin L Watzenboeck,Tyler J Artner,Asma Farhat,Riem Gawish,Karin Lakovits,Anastasiya Hladik,Federica Quattrone,Wolfgang Weninger,Thomas Krausgruber,Shane J F Cronin,Shweta Tikoo,Rohit Jain,Sylvia Knapp,Nikolaus Fortelny,Philipp StarklBACKGROUND Mast cells and macrophages are tissue-resident immune cells frequently found in close proximity in barrier organs. Macrophages show high plasticity and microenvironmental factors, such as cytokines, can influence their phenotype. Mast cells are central in allergic reactions where allergens cause mast cell activation via antigen-specific IgE antibodies and the release of a multitude of inflammatory
-
Type 2 cytokines pleiotropically modulate sensory nerve architecture and neuroimmune interactions to mediate itch. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2025-05-26
Mithilesh Kumar Jha,Yingnan Han,Zhipeng Liu,Yannis Hara,Ingeborg M Langohr,Caroline Morel,Colleen Maloney,Peter Piepenhagen,Heming Xing,Corneliu A Bodea,Dinesh S Bangari,Hamid Mattoo,Alexandra HicksBACKGROUND Anti-type 2 cytokine therapies represent promising interventions for chronic itch; however, their precise mechanisms in restoring nerve architecture and mitigating inflammation and pruritus remain incompletely understood. OBJECTIVES This study aimed to elucidate the mechanistic roles of IL-4, IL-13, and IL-31 in the pathophysiology of itch associated with type 2 inflammatory skin diseases
-
Ingestion of mast cell granules boosts macrophages and drives atypical programming. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2025-05-26
Konstantinos Katsoulis-Dimitriou,Julia Schmidt,Marc Roder,Jan Dudeck,Lars Philipsen,James P Koch,Maria Cattelan,Lea Schmitter,Olga Biskou,Aaron Hoffmann,Michael Mihlan,Rohit Sharma,Johanna Kotrba,Martin Voss,Mahsa Abedi,Ina Sauerland,Stefan Frischbutter,Christina E Zielinski,Robert Geffers,Tim Lämmermann,Andreas J Müller,Sascha Kahlfuß,Anne DudeckBACKGROUND Macrophages (Mphs) exhibit high heterogeneity and plasticity, which is essential for their multifaceted roles in host defense and tissue regeneration. Mast cells (MCs) respond rapidly to injury or infection by releasing intact secretory granules, thereby initiating and potentiating innate and adaptive immunity. OBJECTIVE Since MCs reside in close proximity to Mph in the skin, we decoded
-
Off-schedule patient-reported outcomes in adults with asthma may influence research results. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2025-05-23
Hami Park,Heather Klusaritz,Tyra Bryant-Stephens,A Russell Localio,Daniel Scharfstein,Kadel La Rose,Lenisha Fergus,Philycia Foote,Knashawn H Morales,Xiaoyan Han,Anna U Morgan,Andrea J Apter -
MicroRNA signaling and programming of allergy and asthma: When does the story begin? J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2025-05-22
Rosalind J Wright -
Frequent exacerbator-a novel endotype of pediatric asthma. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2025-05-21
Kieran J Phelan,Gurjit K Khurana HersheyAsthma is a complex and chronic respiratory condition that affects both adult and pediatric populations. Several asthma endotypes have been described; they include endotypes characterized by TH2 cell inflammation, response to viral infection, and exposure to air pollution. Recent evidence has revealed a novel endotype of pediatric asthma, termed the frequent exacerbator (FE) endotype, which is characterized
-
Human Airway Epithelial BAFF is Reduced in Early Life but Virally-induced via JAK/STAT. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2025-05-21
Elizabeth Chorvinsky,Surajit Bhattacharya,Kyle Salka,Bethlehem Solomon Bera,Allison Welham,Ethan Mondell,Geovanny F Perez,Dinesh Pillai,Jyoti Jaiswal,Gustavo Nino,Maria J GutierrezBACKGROUND Early infancy is marked by high susceptibility to severe viral respiratory infections and reduced protective antibody responses, making rapid development of local airway immunity essential. Despite this, the developmental dynamics of human airway B-cells and their interaction with airway epithelial cells (AECs) in early life remain poorly understood. OBJECTIVE To study the developmental
-
Dissecting key contributions of Th2 and Th17 cytokines to atopic dermatitis pathophysiology. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2025-05-21
Luca D Meesters,Janou A Y Roubroeks,Aranka Gerritsen,Niels Velthuijs,Jaimy A Klijnhout,Camille Laberthonnière,Ivonne M van Vlijmen-Willems,Matthias Hübenthal,Diana Rodijk-Olthuis,Rens H W Peters,Gijs Rikken,Silke Szymczak,Nanna Fyhrquist,Harri Alenius,Stephan Weidinger,Jos P H Smits,Musa Mhlanga,Huiqing Zhou,Hanna Niehues,Ellen H van den BogaardBACKGROUND In atopic dermatitis (AD), epidermal disease hallmarks are driven by a complex cutaneous inflammatory milieu that varies between patients. How these variable inflammatory signals affect cellular and molecular epidermal AD phenotypes is difficult to study in vivo. OBJECTIVE We aimed to unravel which AD-associated cytokines drive specific epidermal disease hallmarks. METHODS We utilized primary
-
IKBKB gain of function: An inborn error with clinical heterogeneity progressing toward combined immunodeficiency. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2025-05-20
Julia Körholz,Samantha A M Tromp,Virgil A S H Dalm,Maaike de Bie,Godelieve J de Bree,Ester M M van Leeuwen,Pieter L A Fraaij,Machiel H Jansen,Iris H I M Hollink,Sietse Q Nagelkerke,Susanne Russ,Anne-Kathleen Scholze,Maarja Soomann,Ralf Wiedemuth,Jana Pachlopnik Schmid,Leif G Hanitsch,Catharina Schuetz,Taco W Kuijpers,Hanna IJspeertBACKGROUND The nuclear factor kappa-light-chain enhancer of activated B cells (NF-κB) pathway is a key regulator of immune responses, cell survival, and proliferation. Dysregulation of this signaling pathway is implicated in various human diseases, including inborn errors of immunity. OBJECTIVE We describe the clinical heterogeneity in 16 patients from 4 unrelated families with missense variants in
-
From a study on daily steps to new wearable device-driven asthma prevention strategies. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2025-05-20
Qinhan Liu,Jun Li,Yaling Li -
Regulation of immune cell metabolism by therapeutic normal IgG intravenous immunoglobulin. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2025-05-16
Naresh Rambabu,Fawaz Alzaid,Boban D Anđelković,Sruthi Vijaya Retnakumar,Anupama Karnam,Srinivasa Reddy Bonam,Lucie Orliaguet,Tina Ejlalmanesh,Dorothy Tonui,Emeline Chu-Van,Ludovic Brunet,Nina Bozinovic,Ivan Nemazanyy,Fabian Käsermann,Nicolas Venteclef,Srini V Kaveri,Thibaut Léger,François Fenaille,Benoit Colsch,Jagadeesh BayryBACKGROUND Immune cell metabolism and metabolic end-products influence the nature and magnitude of immune responses. Various autoimmune and inflammatory diseases are associated with dysregulated cellular metabolism. Intravenous immunoglobulin (IVIG), a therapeutic pooled normal IgG, is extensively used for the immunotherapy of a wide-range of autoimmune and inflammatory diseases. Although several cellular
-
The nasal microbiome in early infancy is primarily shaped by the maternal nasal microbiome. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2025-05-16
Bailey E Quinn,José Alejandro Reyes Rodríguez,Emmanuel Kweku Sam,Jasmina Duliman,Elizabeth Denn,Sandra Lee,Liang Shan,Christiana Kuti,Beatrice Irene Nyann,Nicolas Rosario-Matos,Leyao WangBACKGROUND The infant nasal microbiota closely mediates the risks of developing childhood respiratory diseases. However, the primary sources of these early residing bacteria remain largely unknown, preventing the development of microbiome strategies for disease prevention. OBJECTIVE Identify the primary maternal source of bacteria found in the early infant nasal microbiome. METHODS We conducted a birth
-
Cannabinoid WIN55,212-2 restores bronchial epithelium by regulating oxidative stress and STAT6 phosphorylation. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2025-05-16
Mario Pérez-Diego,Alba Angelina,Yağız Pat,Angel Maldonado,Carmen Sevilla-Ortega,Leticia Martín-Cruz,Duygu Yazici,Beate Rückert,Milena Sokolowska,Mar Martín-Fontecha,Mübeccel Akdis,Cezmi A Akdis,Oscar PalomaresBACKGROUND Viral infections and type 2 immune responses perpetuate airway epithelial barrier dysfunction and inflammation, leading to the development and progression of asthma. The synthetic cannabinoid WIN55,212-2 displays anti-inflammatory properties by acting on different immune system cells. OBJECTIVES To investigate the capacity of WIN55,212-2 to restore bronchial epithelial barrier function in
-
The impact of allogeneic hematopoietic stem cell transplantation on pulmonary complications in adults with inborn errors of immunity. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2025-05-14
Aurélie Le Gal,Ambroise Marcais,Céline Goyard,Anne-Laure Brun,Morgane Cheminant,Nizar Mahlaoui,Claire Givel,Colas Tcherakian,Alexandre Chabrol,Frédéric Wallyn,Leonardo Magro,Flore Sicre de Fontbrune,Regis Peffault de la Tour,Abdellatif Tazi,Amira Benattia,Remi Valter,Philippe Devillier,Louis-Jean Couderc,Felipe Suarez,Emilie Catherinot,Hélène SalvatorBACKGROUND Pulmonary involvement (repeated lung infections, lung parenchymal inflammation, scarring, and malignancies) is frequent in patients with inborn errors of immunity (IEI) and accounts for a significant proportion of the disease burden. Allogeneic hematopoietic stem cell transplantation (allo-HSCT) can cure most severe IEI. The indications for allo-HSCT have recently been extended to adults
-
Tryptophan-kynurenine metabolites associate with inflammation and immunologic phenotypes in common variable immunodeficiency. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2025-05-14
Silje F Jørgensen,Peder R Braadland,Thor Ueland,Mai S A Fraz,Annika E Michelsen,Kristian Holm,Liv T Osnes,Marius Trøseid,Per Magne Ueland,Børre Fevang,Pål Aukrust,Johannes R HovBACKGROUND A large proportion of patients with common variable immunodeficiency (CVID) have autoimmune and inflammatory manifestations characterized by chronic T-cell- and monocyte/macrophage activation of unknown etiology. The tryptophan-kynurenine pathway has previously been linked to immune activation involving T cells and monocytes/macrophages, as well as with gut microbial dysbiosis in some inflammatory
-
Expansion of multiple CD4+ T-cell lineages in lymphocytic variant hypereosinophilic syndrome. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2025-05-09
Charles F Anderson,Michelle Makiya,Knaunong Xiong,Lori Penrod,Lauren Wetzler,JeanAnne Ware,Gregory M Constantine,Paneez Khoury,Amy D KlionBACKGROUND Lymphocytic variant hypereosinophilic syndrome (LHES) is a rare disorder characterized by hypereosinophilia, the presence of phenotypically aberrant populations of TH2 lymphocytes, and varied clinical manifestations. Although disease pathogenesis has historically been attributed to IL-5-driven hypereosinophilia, response to eosinophil-lowering biologics is not universal, suggesting a more
-
Dupilumab-induced inhibition of myeloid dendritic cells function via TIM-3-TGF-β1 feedback loop in treatment of atopic dermatitis. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2025-05-08
Yishan Chen,Yuyang Tian,Siqi Liu,Kefan Lin,Rong Tao,Bocheng Wang,Yijia Ruan,Mingjun Hou,Di Wang,Yurong Luo,Chunyan Li,Puyu Zou,Yunsheng Liang,Pan Lai,Danchen Hu,Weiwei DengBACKGROUND Although clinical trials have demonstrated both the efficacy and safety of dupilumab, its impact on dendritic cells (DCs) remains unclear. TIM-3 has emerged as crucial regulators of immune responses in various inflammatory diseases. Understanding the interplay between TIM-3 and the type 2 inflammatory response in atopic dermatitis (AD) could provide valuable insights into the mechanisms
-
Eosinophilic Esophagitis (EoE): Allergy & Immunology Perspective on the Updated Guidelines. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2025-05-06
Emily C McGowan,Benjamin L Wright,Melanie A Ruffner,Robert D Pesek,Marc E Rothenberg,Jonathan M Spergel,Evan S Dellon,Seema S AcevesIn January 2025, the American College of Gastroenterology (ACG) published updated guidelines on the diagnosis and management of eosinophilic esophagitis (EoE). These new guidelines incorporated updated information on the pathophysiology, risk factors, natural history, and treatment of EoE. As these guidelines were primarily intended for practicing gastroenterologists, this Paradigm and Perspectives
-
Dried blood spot proteome identifies subclinical interferon signature in neonates with type I interferonopathy. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2025-05-02
Hiroshi Nihira,Daisuke Nakajima,Kazushi Izawa,Yusuke Kawashima,Hirofumi Shibata,Ryo Konno,Motoko Higashiguchi,Takayuki Miyamoto,Masahiko Nishitani-Isa,Eitaro Hiejima,Yoshitaka Honda,Tadashi Matsubayashi,Takashi Ishihara,Masato Yashiro,Naomi Iwata,Yoko Ohwada,Seiichi Tomotaki,Masahiko Kawai,Kosaku Murakami,Hidenori Ohnishi,Masataka Ishimura,Satoshi Okada,Motoi Yamashita,Tomohiro Morio,Akihiro HoshinoBACKGROUND Type I interferonopathy is characterized by aberrant upregulation of type I interferon signaling. The mRNA interferon signature is a useful marker for activation of the interferon pathway and for diagnosis of type I interferonopathy; however, early diagnosis is challenging. OBJECTIVE This study sought to identify the proteomic interferon signature in dried blood spot (DBS) samples. The aim
-
LONG TERM EFFECTS OF COVID-19 IN PRIMARY IMMUNODEFICIENCY PATIENTS: AN IPOPI WORLDWIDE SURVEY. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2025-04-30
Leanne P M van Leeuwen,Samya Van Coillie,Johan Prévot,Jose Drabwell,Nizar Mahlaoui,Silvia Sánchez-Ramón,M Cecilia Poli,Isabelle Meyts,Adli Ali,David M Lowe,Virgil A S H Dalm,Martine PergentBACKGROUND During the COVID-19 pandemic, many individuals developed persistent symptoms after COVID-19. There is limited data on these long-term effects in the primary immunodeficiency (PID) community. OBJECTIVE This study aimed to understand long-term symptoms post-COVID-19 in PID patients, focusing on prevalence, risk factors, viral persistence and the impact of COVID-19 on their health-related quality
-
Fine resolution of the N-terminal IgE-binding epitope of Ara h 2: discovery of variants with enhanced IgE binding. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2025-04-29
Joshua S Bernstein,Nicole Canon,Catherine H Schein,Werner Braun,Surendra S Negi,Raffi Tchekmedyian,Marina Pozzoli,Edwin H Kim,Michael D Kulis,Thao Vu,Weimin Liu,Xueni Chen,Stephen C DreskinBACKGROUND IgE binding to linear peptides from the N-terminal region of Ara h 2 (epitope 1) is associated with the achievement of sustained unresponsiveness (SU) in young children receiving oral immunotherapy (OIT) and may be important for cross-reactivity between peanuts and tree nuts. This region is also part of the binding site for neutralizing IgG monoclonal antibodies associated with SU following
-
Lessons from the clinical use of ex vivo T-lymphopoiesis assays. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2025-04-28
Grace Evans,Zainab M Golwala,Juan Moises Ocampo-Godinez,Alexandra Y Kreins -
Epinephrine delivery devices: Pharmacokinetics and pharmacodynamics. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2025-04-28
John M Kelso -
Probing the diagnosis of SCID through in vitro T-cell development: Experience in 2 centers in North America. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2025-04-26
Clara Soulard,Francesca Pala,Marita Bosticardo,Elie Haddad -
Selective JAK1 inhibition remits multiorgan autoimmunity in a patient with refractory autoimmune polyendocrine syndrome type 1. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2025-04-24
Yannis Hadjiyannis,Madison N Martinez,Joseph Pechacek,Ibrahim Abukhiran,Deanna Riley,Stefania Pittaluga,Elena M Morariu,Michail S Lionakis,David G Binion,Reed Van Deusen -
Metabotypes are linked to uncontrolled childhood asthma, gut microbiota, and systemic inflammation. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2025-04-23
Mahmoud I Abdel-Aziz,Simone Hashimoto,Anne H Neerincx,Eric G Haarman,Alexander Cecil,Jutta Lintelmann,Michael Witting,Stefanie M Hauck,Nikki Kerssemakers,Joris C Verster,Corinna Bang,Andre Franke,Barbara S Dierdorp,Tamara Dekker,Nariman K A Metwally,Jan Willem Duitman,René Lutter,Mario Gorenjak,Antoaneta A Toncheva,Parastoo Kheiroddin,Susanne Harner,Susanne Brandstetter,Christine Wolff,Paula Corcuera-EloseguiBACKGROUND Childhood asthma has been linked to distinct metabolomic profiles. OBJECTIVE We sought to identify phenotypes (metabotypes) in children with moderate to severe asthma through integrative fecal and serum metabolome analysis. METHODS Children from the Systems Pharmacology Approach to Uncontrolled Pediatric Asthma cohort with Global Initiative for Asthma treatment step 3 or higher were recruited
-
Clarification of the efficacy of tezepelumab in the phase 2a COURSE trial. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2025-04-23
Dave Singh,MeiLan K Han,Jean-Pierre Llanos,Neil Martin,Amit Parulekar,Konstantinos Kostikas,Sandhia S Ponnarambil -
Converging paths toward unified therapeutic approaches in atopic dermatitis, vitiligo, and alopecia areata. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2025-04-22
Lea Tordjman,Kayla D Mashoudy,Tali CzarnowickiEmerging evidence reveals significant epidemiologic, genetic, and immunologic connections between atopic dermatitis, vitiligo, and alopecia areata, challenging previously established notions of their distinct pathogenic and molecular signatures. Exploring these commonalities not only enhances our understanding of each disease's pathogenesis, but also supports the development of unified treatment strategies
-
Harnessing birth cohorts to decode asthma. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2025-04-21
Andrea Apter,Tina Hartert -
From "one airway, one disease" to "one airway, many diseases". J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2025-04-21
Jean Bousquet,Josep M Anto,Tari Haahtela,Bernardo Sousa-Pinto,Mario Morais-Almeida -
Impact of climate change on aerobiology, rhinitis, and allergen immunotherapy: Work Group Report from the Aerobiology, Rhinitis, Rhinosinusitis & Ocular Allergy, and Immunotherapy, Allergen Standardization & Allergy Diagnostics Committees of the American Academy of Allergy, Asthma & Immunology. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2025-04-18
Tolly E G Epstein,Andrew C Rorie,German D Ramon,Anjeni Keswani,Jonathan Bernstein,Rosa Codina,Christopher Codispoti,Timothy Craig,Mark Dykewicz,Denisa Ferastraoaru,Daniel Katz,Jean Kim,Désirée Larenas-Linnemann,Anil Nanda,Anh Nguyen,Mahesh Padukudru Anand,Amber Patterson,Punita Ponda,Elina Toskala,Anita N WasanClimate change is imposing a profound effect on health conditions triggered by environmental exposures. Climate change has affected aeroallergens in numerous ways, including: (1) changes in the vegetation microbiome distribution, (2) increases in C4 grasses globally, (3) increased occurrence of acute weather events, (4) increases in ambient temperature that amplify fungal spore concentration and pollen
-
Understanding the childhood origins of asthma and chronic obstructive pulmonary disease: Insights from birth cohorts and studies across the life-span. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2025-04-17
Tina Hartert,Julie Nyholm Kvysgaard,Linesri Thaver,Aisha Suara-Istanbouli,James P Allinson,Heather J ZarBirth cohorts have identified modifiable risk factors for asthma and respiratory health in children and adults, demonstrating the important role and pathways through which early-life events influence not only child outcomes but also adult health, disease, and mortality. This focused literature update from 2021 to 2024 summarizes birth cohort studies across the life-span that contribute to our understanding
-
Asthma treatment response modified by fine particulate matter, nitrogen dioxide, and ozone among Black children: A reanalysis of the AsthmaNet Best African American Response to Asthma Drugs trial. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2025-04-15
Lizbeth F Gómez,Ellen J Kinnee,Michael T Young,Joel D Kaufman,Anne M Fitzpatrick,Sharmilee M Nyenhuis,Julian Solway,Steven R White,Edward T Naureckas,Wanda Phipatanakul,Michael E Wechsler,Susan J Kunselman,David T Mauger,Leslie A McClure,Usama Bilal,Stephen C Lazarus,Fernando Holguin,Jane E CloughertyBACKGROUND Asthma morbidity significantly affects children of all racial backgrounds; however, Black children experience a greater disease burden than children from other racial groups. Despite the known influence of air pollution on asthma outcomes, its role in the efficacy of asthma treatments remains underexplored. OBJECTIVE We sought to examine how exposure to particulate matter <2.5 μm (PM2.5)
-
Baseline basophil activation and early suppression is associated with clinical outcome after peanut sublingual immunotherapy. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2025-04-15
Jessica R Humphrey,Rishu Guo,Xiaohong Yue,Corinne A Keet,Yamini V Virkud,J Andrew Bird,A Wesley Burks,Edwin H Kim,Johanna M Smeekens,Michael D KulisBACKGROUND Sublingual immunotherapy (SLIT) was recently shown to safely induce desensitization and remission of peanut allergy in 1- to 4-year-old children. OBJECTIVE Basophil activation has been shown to be suppressed in allergen-specific immunotherapy. We aimed to evaluate the timing of basophil suppression during peanut SLIT and its impact on clinical outcomes. METHODS A total of 50 children with
-
Innate immune reprogramming in circulating neutrophils of COPD patients. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2025-04-14
Barbara Mariotti,Chiara Bracaglia,Sara Gasperini,Giulia Sartori,Ernesto Crisafulli,Flavia BazzoniBACKGROUND Chronic obstructive pulmonary disease (COPD) involves both local and systemic neutrophilic inflammation, with dysregulation in blood neutrophil numbers, frequencies, and functions. OBJECTIVE We sought to characterize the transcriptional and epigenetic profiles of circulating neutrophils in patients with COPD and explore correlations with neutrophil dysfunction and clinical disease parameters
-
Advancing birth cohort studies using administrative and other research-independent data repositories: Opportunities and challenges. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2025-04-11
Steven M Brunwasser,Allison K Warner,Christian Rosas-Salazar,Pingsheng WuThe birth cohort study design is an essential epidemiologic tool for investigating the developmental origins of health and disease. Birth cohorts have greatly improved the etiologic understanding of asthma and allergic diseases, setting the stage for advancements in translational interventions. Increasingly, investigators leverage data repositories that have been compiled and maintained independently
-
Integrating geospatial data with birth cohorts to explore social determinants of health and asthma. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2025-04-11
Patrick H Ryan,Jeff Blossom,Cole Brokamp,Antonella Zanobetti,Diane R GoldPlace-based measures of environmental exposures, climate, neighborhood characteristics, housing, and other social determinants of health are powerful predictors of health outcomes, including asthma. In addition, social determinants of health are likely causes of the persistent racial and ethnic disparities in asthma prevalence and morbidity. The objectives of this commentary are to (1) provide an overview
-
Effects of inflammatory endotypes on disease trajectory in chronic rhinosinusitis with nasal polyps. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2025-04-10
Christina Dorismond,Yash Trivedi,Mason R Krysinski,Rory J Lubner,Li-Ching Huang,Sandeep Goswami,Quanhu Sheng,Rakesh K Chandra,Naweed I Chowdhury,Justin H TurnerBACKGROUND Although phenotypic features have traditionally guided treatment in chronic rhinosinusitis, recent research has favored categorization on the basis of inflammatory endotype. However, the impact of endotypic differeces on clinical outcomes remains largely unknown. OBJECTIVE We sought to compare disease trajectory, primarily time-to-polyp recurrence, between chronic rhinosinusitis with nasal
-
Lipopolysaccharide-responsive and beige-like anchor protein (LRBA) functional deficiency caused by biallelic LRBA missense variants characterized by Evans syndrome or colitis. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2025-04-10
Samuel C C Chiang,Li Yang,Erika Owsley,Ammar Husami,Nagako Akeno,Cristina Cobb,Nicholas L Hartog,Araceli Elizalde,Christine M Seroogy,Geraldine Blanchard-Rohner,Xiao P Peng,Rae Brager,David Buchbinder,Eleanor Cook,Lindsay Phillips,Snezana Maricic,Tatiana Kalashnikova,Beata Derfalvi,Victoria R Dimitriades,Luis E Murguía-Favela,Maria J Gutierrez,Anitha Shrikhande,MacGregor Steele,Jo L Wilson,Nicola ABACKGROUND Biallelic loss-of-function mutations in the lipopolysaccharide-responsive and beige-like anchor (LRBA) gene lead to a severe syndrome of early-onset immune dysregulation called LRBA deficiency. Monoallelic CTLA4 mutations lead to a similar phenotype. In both conditions, cytotoxic T lymphocyte-associated protein 4 (CTLA-4) levels are significantly decreased. In previously reported cases of
-
Endotypes of chronic spontaneous urticaria and angioedema. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2025-04-10
Dennis Wong,Susan Waserman,Gordon L SussmanThe current understanding of chronic spontaneous urticaria (CSU) suggests that a complex network of inflammatory pathways is involved in its pathogenesis. Recent development highlighted autoimmunity as one of the key pathogenic mechanisms of CSU. Two endotypes, type I autoallergic (associated with IgE antibodies against autoantigens) and type IIb autoimmune (mediated by IgG autoantibodies against IgE
-
Chimeric antigen receptor therapies: Development, design, and implementation. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2025-04-10
Madeline J Lee,Frank Cichocki,Jeffrey S MillerChimeric antigen receptor (CAR) T and natural killer (NK) cell therapies represent a promising strategy for the treatment of cancers and other chronic diseases. Engineered CAR constructs endow immune cells with the ability to target desired antigens with high specificity, allowing for directed responses to antigen-expressing cells. CAR T and NK cells have shown marked success in the treatment of hematologic
-
A new era for complement therapeutics. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2025-04-10
Trent M Woodruff -
Inside job: Roles of intracellular C3. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2025-04-05
Behdad Afzali,Parul Singh,Md Tajmul,Claudia KemperOur understanding of the complement system continues to grow beyond that of a liver-derived systemically operative mechanism of pathogen clearance to a central orchestrator of single-cell behavior and tissue biology. These expanded activities reflect the extrahepatic and local production of complement by many, if not most, cells, and the unexpected recent finding that complement also serves important
-
Nasal transcriptome differences preceding recurrent wheezing in infancy. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2025-04-04
Poshmaal Dhar,Martin O'Hely,Luba Sominsky,Sarah Ashley,Sarath C Ranganathan,Peter D Sly,Fiona Collier,Mimi L K Tang,Rachel Morgan,Toby Mansell,Richard Saffery,David Burgner,Anne-Louise Ponsonby,Peter Vuillermin,BACKGROUND Mucosal immune responses and epithelial barrier function are key emerging determinants of susceptibility to wheezing illnesses in early life. OBJECTIVE We sought to investigate the association between nasal transcriptome in healthy infants and the subsequent incidence of recurrent wheeze. METHODS In a population-derived prebirth cohort study, whole-transcriptome sequencing was performed
-
Early-life wheeze trajectories are associated with distinct asthma transcriptomes later in life. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2025-04-04
Kieran J Phelan,Krishna M Roskin,Jeffrey W Burkle,Wan-Chi Chang,Lisa J Martin,Jocelyn M Biagini,Latha Satish,David B Haslam,Daniel Spagna,Seth Jenkins,Elsie Parmar,Leonard B Bacharier,Tebeb Gebretsadik,Michelle Gill,Diane R Gold,Daniel J Jackson,Christine C Johnson,Susan V Lynch,Kathryn E McCauley,Chris G McKennan,Rachel Miller,Carole Ober,Dennis R Ownby,Patrick H Ryan,Nathan Schoettler,Sweta SinghBACKGROUND Early childhood wheeze is characterized by heterogeneous trajectories having differential associations with later-life asthma development. OBJECTIVE We sought to determine how early-life wheeze trajectories impact later life asthma gene expression. METHODS The Children's Respiratory Environmental Workgroup is a collective of 12 birth cohorts, 7 of which conducted an additional visit with
-
TNF-α counters skin inflammation by restraining mast cell-dependent thymic stromal lymphopoietin production. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2025-04-04
Davender Redhu,Vandana Kumari,Kristin Franke,Karin Hartmann,Margitta Worm,Magda BabinaBACKGROUND TNF-α is an important proinflammatory cytokine, but its neutralization in the management of inflammatory skin disorders like psoriasis may trigger eczematous skin lesions as an adverse reaction. OBJECTIVES This study aimed to elucidate whether TNF-α may protect from skin inflammation and to identify in detail the underlying mechanisms. METHODS Wild-type, TNF-α-deficient, thymic stromal lymphopoietin
-
Gene-by-environment interactions modulate the infant gut microbiota in asthma and atopy. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2025-04-03
Sara A Stickley,Zhi Yi Fang,Amirthagowri Ambalavanan,Yang Zhang,Amanda M Zacharias,Charisse Petersen,Darlene Dai,Meghan B Azad,Jeffrey R Brook,Piushkumar J Mandhane,Elinor Simons,Theo J Moraes,Michael G Surette,Stuart E Turvey,Padmaja Subbarao,Qingling DuanBACKGROUND Gut microbiota has been associated with health and susceptibility to childhood diseases, including asthma and allergies. However, the genomic factors contributing to interindividual variations in gut microbiota remain poorly understood. OBJECTIVE We sought to integrate host genomics with early-life exposures to investigate main and interaction effects on gut microbiota during the first year
-
Nasal production of IL-26 involving T cells in smokers with and without chronic obstructive pulmonary disease. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2025-03-28
Julia Arebro,Nikolaos Pournaras,Patricia Ramos-Ramírez,Eduardo I Cardenas,Elga Bandeira,Karlhans Fru Che,Bettina Brundin,Apostolos Bossios,Reza Karimi,Sven Nyrén,Pär Stjärne,Magnus Sköld,Anders LindénBACKGROUND Novel specific therapy in chronic obstructive pulmonary disease (COPD) will require accessible targets for endotyping to identify responsive patients. It is therefore of interest that IL-26 in the bronchoalveolar space is enhanced and associates with bronchoalveolar pathology among long-term smokers (LTS) with and without COPD. OBJECTIVE We determined whether IL-26 in the nasal cavity can
-
Immunogenicity of adjuvanted recombinant SARS-CoV-2 spike protein vaccine after earlier mRNA vaccine doses. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2025-03-26
Jeffrey M Adelglass,Paul Bradley,Miranda R Cai,Gordon Chau,Raj Kalkeri,Shane Cloney-Clark,Mingzhu Zhu,Zhaohui Cai,Mark Eickhoff,Joyce S Plested,Raburn M Mallory,Lisa M DunkleBACKGROUND To support heterologous vaccine regimens, periodic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) revaccination requires immunogenicity and safety data for adjuvanted protein-based vaccines following prior mRNA doses. OBJECTIVE We sought to assess noninferiority of neutralizing antibody (nAb) titers following a second dose versus a first dose (in a prior study) of an SARS-CoV-2
-
Biomarker-driven drug development for allergic diseases and asthma: An FDA public workshop. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2025-03-26
Ronald L Rabin,Matthew C Altman,S Hasan Arshad,Richard D Beger,Pamela A Frischmeyer-Guerrerio,Elena Goleva,Robert G Hamilton,Gurjit K Khurana Hershey,Mohamed H Shamji,Hugh A Sampson,Alexandra F Santos,Wayne G Shreffler,Alkis Togias,Stefan Vieths,Erik Wambre,Sally E Wenzel,Kathleen Hise,Joohee Lee,Anubha Tripathi,Jay E SlaterThe US Food and Drug Administration (FDA) hosted a workshop on February 22, 2024, to discuss the status of biomarkers in drug development for allergic asthma and food allergy. The workshop provided a forum for open discussion among regulators, academicians, National Institutes of Health staff and industry to inform stakeholders of the requirements for the FDA to adopt a biomarker as a surrogate end
-
Update on the genetics of allergic diseases. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2025-03-24
Lucinda P Lawson,Sreeja Parameswaran,Ronald A Panganiban,Gregory M Constantine,Matthew T Weirauch,Leah C KottyanThe field of genetic etiology of allergic diseases has advanced significantly in recent years. Shared risk loci reflect the contribution of genetic factors to the sequential development of allergic conditions across the atopic march, while unique risk loci provide opportunities to understand tissue specific manifestations of allergic disease. Most identified risk variants are noncoding, indicating
-
Clinical efficacy and mechanisms of biologics for chronic rhinosinusitis with nasal polyps. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2025-03-23
Radomir Kratchmarov,Tiffany Dharia,Kathleen BuchheitThe management of chronic rhinosinusitis with nasal polyps (CRSwNP) can be challenging, particularly when standard treatments including intranasal corticosteroids and endoscopic sinus surgery do not result in adequate symptom control. CRSwNP is frequently characterized by a type 2 immune signature, and many patients have other comorbid type 2 conditions, including asthma. There are currently 3 biologic
-
Complement factor I deficiency: Diverse phenotypes. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2025-03-22
Ruby Moreno,Lori Broderick -
Closing in on epithelial barrier dysfunction in chronic rhinosinusitis. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2025-03-20
Nora A Barrett -
Unraveling the heterogeneity of asthma: Decoding subtypes of asthma. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2025-03-19
Anne L Fuhlbrigge,Sunita SharmaAsthma is a heterogeneous disease with diverse underlying mechanisms contributing to disease susceptibility and progression. Asthma endotypes and phenotypes have emerged as critical frameworks to help understand the variation in disease presentation and response to therapies. Phenotypes are the observable characteristics or traits of an organism that are produced by the interaction of genotype and
-
MRGPRX2 gain-of-function mutation drives enhanced mast cell reactivity in chronic spontaneous urticaria. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2025-03-18
Dan Ye,Yuxin Zhang,Xi Zhao,Hongmei Zhou,Jiahua Guo,Mengyao Yang,Xinwu Niu,Xiaopeng Wang,Jingyi Yuan,Jianwen Ren,Songmei Geng,Weihui Zeng,Zhao WangBACKGROUND Mast cell (MC) activation plays a central role in the pathogenesis of chronic spontaneous urticaria (CSU). Mutations in MC receptors have been suggested as a potential mechanism underlying CSU. MRGPRX2 has been proposed to contribute to the pathogenesis of CSU. However, the relationship between mutations in MRGPRX2 and their impact on disease severity and receptor function remains poorly
-
Clinical and mechanistic advancements in aspirin exacerbated respiratory disease. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2025-03-18
Shabnam Elahi,Anju T Peters,Atsushi Kato,Whitney W StevensAspirin-exacerbated respiratory disease (AERD) is characterized by the clinical triad of chronic rhinosinusitis with nasal polyps, asthma, and a hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs). AERD is estimated to occur in as many as 15% of patients with chronic rhinosinusitis with nasal polyps and/or asthma. Uniquely, patients with AERD develop respiratory symptoms within 30 to
-
IRF2BP2 deficiency: An important form of common variable immunodeficiency with inflammation. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2025-03-14
Chioma Udemgba,Bethany Pillay,Samantha Shafer,Angelika Alberstadt,Michael Abers,Olivier Gilliaux,Karin Chen,William Rae,Leif Hanitsch,Horst Von Bernuth,Joao Farela Neves,Nikita Raje,Leen Moens,P Martin van Hagen,Jenna Bergerson,Nicholas Hartog,Tim Niehues,Gregor Dückers,Emilia Falcone,Michael Keller,Amy Hsu,Isabelle Meyts,Steven M HollandBACKGROUND IRF2BP2 is a transcription factor that plays an important role in regulating immune pathways, angiogenesis, apoptosis, and cell differentiation. Defects in this gene have been implicated in immunodeficiency. OBJECTIVES To deepen the understanding of the clinical implications of IRF2BP2 variants, we sought to clinically characterize and functionally test 34 individuals with IRF2BP2 variants
-
Evaluating hypogammaglobulinemia after CD19 CAR T-cell therapy. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2025-03-14
Pui-Ying Leong,Poi Kuo,James Cheng-Chung Wei -
Upper airway comorbidities of asthma in patients with aspirin-exacerbated respiratory disease. J. Allergy Clin. Immunol. (IF 11.4) Pub Date : 2025-03-14
Piotr Szatkowski,Lucyna Mastalerz